261 related articles for article (PubMed ID: 26786778)
21. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
[TBL] [Abstract][Full Text] [Related]
22. Neuregulin-1 triggers GLUT4 translocation and enhances glucose uptake independently of insulin receptor substrate and ErbB3 in neonatal rat cardiomyocytes.
Heim P; Morandi C; Brouwer GR; Xu L; Montessuit C; Brink M
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118562. PubMed ID: 31669265
[TBL] [Abstract][Full Text] [Related]
23. HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.
Nayak BK; Shanmugasundaram K; Friedrichs WE; Cavaglierii RC; Patel M; Barnes J; Block K
Diabetes; 2016 May; 65(5):1387-97. PubMed ID: 26908870
[TBL] [Abstract][Full Text] [Related]
24. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Gallo LA; Ward MS; Fotheringham AK; Zhuang A; Borg DJ; Flemming NB; Harvie BM; Kinneally TL; Yeh SM; McCarthy DA; Koepsell H; Vallon V; Pollock C; Panchapakesan U; Forbes JM
Sci Rep; 2016 May; 6():26428. PubMed ID: 27226136
[TBL] [Abstract][Full Text] [Related]
25. Critical role for osteopontin in diabetic nephropathy.
Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
[TBL] [Abstract][Full Text] [Related]
26. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
27. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
[TBL] [Abstract][Full Text] [Related]
28. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
29. Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.
El Boustany R; Taveau C; Chollet C; Velho G; Bankir L; Alhenc-Gelas F; Roussel R; Bouby N
J Diabetes Complications; 2017 Jun; 31(6):929-932. PubMed ID: 28412033
[TBL] [Abstract][Full Text] [Related]
30. AMPKα inactivation destabilizes atherosclerotic plaque in streptozotocin-induced diabetic mice through AP-2α/miRNA-124 axis.
Liang WJ; Zhou SN; Shan MR; Wang XQ; Zhang M; Chen Y; Zhang Y; Wang SX; Guo T
J Mol Med (Berl); 2018 May; 96(5):403-412. PubMed ID: 29502204
[TBL] [Abstract][Full Text] [Related]
31. The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.
Watson AM; Li J; Schumacher C; de Gasparo M; Feng B; Thomas MC; Allen TJ; Cooper ME; Jandeleit-Dahm KA
Diabetologia; 2010 Jan; 53(1):192-203. PubMed ID: 19862499
[TBL] [Abstract][Full Text] [Related]
32. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
Klemis V; Ghura H; Federico G; Würfel C; Bentmann A; Gretz N; Miyazaki T; Gröne HJ; Nakchbandi IA
Kidney Int; 2017 Jun; 91(6):1374-1385. PubMed ID: 28159318
[TBL] [Abstract][Full Text] [Related]
33. CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose-Induced Mesangial Injury.
Cui S; Zhu Y; Du J; Khan MN; Wang B; Wei J; Cheng JW; Gordon JR; Mu Y; Li F
Endocrinology; 2017 Jun; 158(6):1671-1684. PubMed ID: 28387853
[TBL] [Abstract][Full Text] [Related]
34. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
[TBL] [Abstract][Full Text] [Related]
35. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
36. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
37. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
[TBL] [Abstract][Full Text] [Related]
38. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
Lassila M; Seah KK; Allen TJ; Thallas V; Thomas MC; Candido R; Burns WC; Forbes JM; Calkin AC; Cooper ME; Jandeleit-Dahm KA
J Am Soc Nephrol; 2004 Aug; 15(8):2125-38. PubMed ID: 15284298
[TBL] [Abstract][Full Text] [Related]
39. The protective role of neuregulin-1: A potential therapy for sepsis-induced cardiomyopathy.
Zhou Q; Pan X; Wang L; Wang X; Xiong D
Eur J Pharmacol; 2016 Oct; 788():234-240. PubMed ID: 27346832
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
